IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
Marie was honored for her significant contributions to IQVIA including increasing the patient voice in research and care delivery combined with her dedication to advancing women in the healthcare industry. She joined IQVIA through the 2021 acquisition of Inteliquet and quickly integrated her team into the larger organization, earning the trust of executives. Marie's strategic leadership of nearly 800 colleagues across the
Joanne was recognized for her scientific leadership and commercial acumen. She has played key roles in establishing prominent healthcare institutions in the
"Joanne and Marie exemplify IQVIA's culture of innovation, leadership and passion for improving healthcare,” said IQVIA Chairman and CEO Ari Bousbib. “Their recognition by the HBA is a well-deserved honor that highlights their impact and commitment.”
Marie, Joanne and other 2025 HBA honorees will be celebrated at HBA’s Woman of the Year Annual celebration in
About the Awards
The Healthcare Businesswomen’s Association (HBA) is a global organization committed to furthering the advancement and impact of women within healthcare. Its annual Luminary Award recognizes seasoned and talented professionals who have significantly impacted the healthcare industry by leading and serving as role models, actively mentoring others, and driving impactful progress at their organizations and within the industry. The Rising Star Award recognizes individuals who have made significant contributions to their respective company, exemplified strong and innovative leadership, and have worked with others to help them achieve their goals. For more information, visit HBAnet.org.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250428034181/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Communications (alissa.maupin@iqvia.com)
+1 919.923.6785
Source: IQVIA
